Free Trial

RegeneRx Biopharmaceuticals (RGRX) Stock Chart & Stock Price History

RegeneRx Biopharmaceuticals logo
$0.0050 0.00 (0.00%)
As of 08/1/2025

RegeneRx Biopharmaceuticals Stock Price Performance

The RegeneRx Biopharmaceuticals (RGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 257.14%, with a year-to-date return of 257.14%. In the past month, the stock has increased 2,400.00%, reflecting recent market activity.

As of the latest close, RegeneRx Biopharmaceuticals traded at $0.01 with a market cap of and volume of 107 shares. Five years ago, the stock traded at a split-adjusted price of $38.00, representing a 99.99% decrease over that period. At the time, it had a market cap of and a volume of 335 shares.

Receive RGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

5 Day
Performance
+2,400.00%
1 Month
Performance
+2,400.00%
3 Month
Performance
N/A
Year-To-Date
Performance
+257.14%
1 Year
Performance
+257.14%
5 Year
Performance
-99.99%

RGRX Stock Chart for Saturday, August, 2, 2025

RegeneRx Biopharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/01/2025$0.01$0.01$0.01$0.01107 shs$10,000.00
07/31/2025$0.01$0.01$0.01$0.01107 shs$0.00
07/30/2025$0.00$0.01
+2,400.00%
$0.01$0.01107 shs$0.00
07/29/2025$0.00$0.00$0.00$0.00520 shs$0.00
07/28/2025$0.00$0.00$0.00$0.00520 shs$0.00
07/25/2025$0.00$0.00$0.00$0.002 shs$0.00
07/24/2025$0.00$0.00$0.00$0.00745 shs$0.00
07/23/2025$0.00$0.00$0.00$0.00745 shs$0.00
07/17/2025$0.00$0.00$0.00$0.0020 shs$0.00
07/15/2025$0.00$0.00$0.00$0.0025 shs$0.00
07/09/2025$0.00$0.00$0.00$0.0063 shs$0.00
07/07/2025$0.00$0.00$0.00$0.001 shs$0.00
07/04/2025$0.00$0.00$0.00$0.001 shs$0.00
07/02/2025$0.00$0.00$0.00$0.00100 shs$0.00
07/01/2025$0.00$0.00$0.00$0.00100 shs$0.00

This page (OTCMKTS:RGRX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners